Hematology · USMLE Step 1 and Step 2
Aspirin song
Aspirin - Mechanism, Uses & Toxicity, as a song. Hear the short teaser here. The full song is on YouTube and Spotify.

Aspirin
Key points in this song10
- Aspirin irreversibly inhibits COX-1 and COX-2 by acetylating a serine residue, blocking thromboxane A2 in platelets and prostacyclin in endothelium.
- At low doses (81 mg), aspirin preferentially inhibits platelet COX-1, reducing TXA2 and producing an antiplatelet effect that lasts the platelet's lifetime (7–10 days).
- At high doses, aspirin inhibits COX-2 in the endothelium, reducing prostacyclin (PGI2), which can paradoxically increase thrombotic risk.
- Aspirin is the drug of choice for immediate use in acute MI and ischemic stroke; it reduces mortality when given within 24 hours of an acute coronary event.
- Aspirin is contraindicated in children with viral illness due to risk of Reye syndrome (hepatic encephalopathy with mitochondrial dysfunction and microvesicular steatosis).
- Salicylate toxicity initially causes respiratory alkalosis (direct stimulation of the medullary respiratory center), followed by an elevated anion gap metabolic acidosis.
- Chronic aspirin use can cause peptic ulcer disease by reducing PGE2-mediated mucosal protection; co-prescribe a PPI in high-risk patients.
- Aspirin hypersensitivity triad (Samter's triad): asthma, nasal polyps, and aspirin/NSAID-induced bronchospasm, mediated by shunting arachidonic acid toward leukotrienes.
- Aspirin is used in Kawasaki disease (high-dose anti-inflammatory phase, then low-dose antiplatelet phase) and in pre-eclampsia prophylaxis starting at 12–16 weeks gestation in high-risk patients.
- Uricosuric effect occurs at high doses; low doses decrease uric acid excretion and can precipitate gout — a classic USMLE dose-dependent distinction.
About this song
SubjectHematology
Full song5:37 min
Released07 Aug 2026
ExamUSMLE Step 1 and Step 2









